Understanding pen-injector use errors and their implications
The proliferation of pen-injectors used by laypeople for self-administration of medication in their homes has caused regulators, such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to task manufacturers with providing sufficient evidence to demonstrate that all users, especially laypeople, can safely and effectively administer an accurate dose. Much of this evidence is comprised of manufacturers anticipating use errors through preliminary analyses and, to the extent possible, “designing out” these potential errors to create a more intuitive, safe, and effective product design.
Top pen-injector use errors | Emergo by UL
Top pen-injector use errors and how to mitigate them
An Emergo by UL human factors specialist discusses the top use errors observed when evaluating pen-injector interactions during a usability study, and how manufacturers can work towards mitigating such use errors.
www.emergobyul.com